![Why a New Psoriasis Disease Severity Classification System Will Better Serve Psoriasis Patients - International Psoriasis Council Why a New Psoriasis Disease Severity Classification System Will Better Serve Psoriasis Patients - International Psoriasis Council](https://psoriasiscouncil.org/wp-content/uploads/2022/06/Blog-Expert-Insights-Classification-Graphic-1024x576.png)
Why a New Psoriasis Disease Severity Classification System Will Better Serve Psoriasis Patients - International Psoriasis Council
Psoriasis Drugs Market Research, Forecast Analysis by Sales Channel (Hospital Pharmacy, Drug Stores, Online Pharmacy), Market
![JFB | Free Full-Text | Nanoscale Topical Pharmacotherapy in Management of Psoriasis: Contemporary Research and Scope JFB | Free Full-Text | Nanoscale Topical Pharmacotherapy in Management of Psoriasis: Contemporary Research and Scope](https://www.mdpi.com/jfb/jfb-14-00019/article_deploy/html/images/jfb-14-00019-g001.png)
JFB | Free Full-Text | Nanoscale Topical Pharmacotherapy in Management of Psoriasis: Contemporary Research and Scope
![Nail Psoriasis: Treatment Options and Management Strategies in Special Patient Populations | International Journal of Dermatology and Venereology Nail Psoriasis: Treatment Options and Management Strategies in Special Patient Populations | International Journal of Dermatology and Venereology](https://mednexus.org/cms/asset/22ccc2c7-9463-4702-a8f0-6e4ef35bea78/jd9.0000000000000187.png)
Nail Psoriasis: Treatment Options and Management Strategies in Special Patient Populations | International Journal of Dermatology and Venereology
![Women Have Lower Incidence of Severe Psoriasis & Itch Less As Compared to Men, Says Study | LatestLY Women Have Lower Incidence of Severe Psoriasis & Itch Less As Compared to Men, Says Study | LatestLY](https://st1.latestly.com/wp-content/uploads/2022/06/resize-1-22-380x214.jpg)
Women Have Lower Incidence of Severe Psoriasis & Itch Less As Compared to Men, Says Study | LatestLY
![Topical treatment adherence and associated factors in patients with psoriasis: A single center, cross‐sectional study - Nasimi - 2022 - Dermatologic Therapy - Wiley Online Library Topical treatment adherence and associated factors in patients with psoriasis: A single center, cross‐sectional study - Nasimi - 2022 - Dermatologic Therapy - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/a0aafd44-9558-41dd-bdfa-a401ea77e2b6/dth.v35.7.cover.jpg?trick=1694278234115)
Topical treatment adherence and associated factors in patients with psoriasis: A single center, cross‐sectional study - Nasimi - 2022 - Dermatologic Therapy - Wiley Online Library
![Bristol Myers on track for 3rd new drug launch of 2022 with latest deucravacitinib data | Fierce Biotech Bristol Myers on track for 3rd new drug launch of 2022 with latest deucravacitinib data | Fierce Biotech](https://qtxasset.com/quartz/qcloud5/media/image/GettyImages-1300036753thisone.jpg?VersionId=gN_SUq436ytBNKaO0mAKZU9B0KWYhqt5)
Bristol Myers on track for 3rd new drug launch of 2022 with latest deucravacitinib data | Fierce Biotech
![Molecules | Free Full-Text | Promising Strategies in Plant-Derived Treatments of Psoriasis-Update of In Vitro, In Vivo, and Clinical Trials Studies Molecules | Free Full-Text | Promising Strategies in Plant-Derived Treatments of Psoriasis-Update of In Vitro, In Vivo, and Clinical Trials Studies](https://pub.mdpi-res.com/molecules/molecules-27-00591/article_deploy/html/images/molecules-27-00591-g001.png?1643038032)
Molecules | Free Full-Text | Promising Strategies in Plant-Derived Treatments of Psoriasis-Update of In Vitro, In Vivo, and Clinical Trials Studies
![Human umbilical cord mesenchymal stem cells for psoriasis: a phase 1/2a, single-arm study | Signal Transduction and Targeted Therapy Human umbilical cord mesenchymal stem cells for psoriasis: a phase 1/2a, single-arm study | Signal Transduction and Targeted Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41392-022-01059-y/MediaObjects/41392_2022_1059_Fig1_HTML.png)